Keros Therapeutics IncKeros Therapeutics Inc - ESG Rating & Company Profile powered by AI

Industry Group:Pharmaceuticals

This ESG rating covers 17 UN Sustainable Development Goals including: 'Gender Equality', 'Sustainable Cities & Communities' and 'Life below Water'. This report of Keros Therapeutics Inc is prepared by All Street Sevva using cutting edge Cognitive Robots. This page displays a free Environmental, Social and Governance report covering Keros Therapeutics Inc.

Keros Therapeutics Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 4.9; made up of an environmental score of 3.2, social score of 4.8 and governance score of 6.7.

SDG Transparency Score for Keros Therapeutics Inc 
Low
0 - 3

4.9

Medium Impact
4 - 6
High
7 - 10
Last Score Update: 2023-07-01
What drives the score for Keros Therapeutics Inc 
3.2

Environmental

4.8

Social

6.7

Governance

Detailed ESG Breakdown
SEVVA Platform offers unique drill down to the underlying sources powering the ratings. Break down your ESG analysis by 17 UN SDGs and 8 additional governance factors.

Peer Group Comparison

RankCompanySDG Transparency Score Performance
1Novartis AG
9.2
High
2Daiichi Sankyo Co Ltd
8.9
High
1047SQZ Biotechnologies Co
5.0
High
1047Zenabis Global Inc
5.0
High
1082Keros Therapeutics Inc
4.9
High
1082AngioLab Inc
4.9
High
1082Annexon Inc
4.9
High
.........
2749Xynomic Pharmaceuticals Holdings Inc
0.0
Low
2749Zyden Gentec Ltd
0.0
Low
.........
View the full peer group of 3273 companies on the SEVVA platformSign up for free
Peer Companies Benchmark
SEVVA Platform benchmarks each company against a peer group. View the full score distribution for peers by logging into SEVVA

Frequently Asked Questions

Does Keros Therapeutics Inc have an accelerator or VC vehicle to help deliver innovation?

LockedSign up for free to unlock

Does Keros Therapeutics Inc disclose current and historical energy intensity?

LockedSign up for free to unlock

Does Keros Therapeutics Inc report the average age of the workforce?

LockedSign up for free to unlock

Does Keros Therapeutics Inc reference operational or capital allocation in relation to climate change?

LockedSign up for free to unlock

Does Keros Therapeutics Inc disclose its ethnicity pay gap?

LockedSign up for free to unlock

Does Keros Therapeutics Inc disclose cybersecurity risks?

LockedSign up for free to unlock

Does Keros Therapeutics Inc offer flexible work?

LockedSign up for free to unlock

Does Keros Therapeutics Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?

LockedSign up for free to unlock

Does Keros Therapeutics Inc disclose the number of employees in R&D functions?

LockedSign up for free to unlock

Does Keros Therapeutics Inc conduct supply chain audits?

LockedSign up for free to unlock

Does Keros Therapeutics Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')

LockedSign up for free to unlock

Does Keros Therapeutics Inc conduct 360 degree staff reviews?

LockedSign up for free to unlock

Does Keros Therapeutics Inc disclose the individual responsible for D&I?

LockedSign up for free to unlock

Does Keros Therapeutics Inc disclose current and historical air emissions?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')

LockedSign up for free to unlock

Is executive remuneration linked to climate performance?

LockedSign up for free to unlock

Does the Board describe its role in the oversight of climate-related risks and opportunities?

LockedSign up for free to unlock

Does Keros Therapeutics Inc disclose current and / or historical scope 2 emissions?

LockedSign up for free to unlock

Does Keros Therapeutics Inc disclose water use targets?

LockedSign up for free to unlock

Does Keros Therapeutics Inc have careers partnerships with academic institutions?

LockedSign up for free to unlock

Did Keros Therapeutics Inc have a product recall in the last two years?

LockedSign up for free to unlock

Does Keros Therapeutics Inc disclose incidents of discrimination?

LockedSign up for free to unlock

Does Keros Therapeutics Inc allow for Work Councils/Collective Agreements to be formed?

LockedSign up for free to unlock

Has Keros Therapeutics Inc issued a profit warning in the past 24 months?

LockedSign up for free to unlock

Does Keros Therapeutics Inc disclose parental leave metrics?

LockedSign up for free to unlock

Does Keros Therapeutics Inc disclose climate scenario or pathway analysis?

LockedSign up for free to unlock

Does Keros Therapeutics Inc disclose current and / or historical scope 1 emissions?

LockedSign up for free to unlock

Are Operating Expesnses linked to emissions reduction?

LockedSign up for free to unlock

Does Keros Therapeutics Inc disclose the pay ratio of women to men?

LockedSign up for free to unlock

Does Keros Therapeutics Inc support suppliers with sustainability related research and development?

LockedSign up for free to unlock

Does Keros Therapeutics Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?

LockedSign up for free to unlock

Does Keros Therapeutics Inc reflect climate-related risks in its financial statements?

LockedSign up for free to unlock

Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')

LockedSign up for free to unlock

Is Keros Therapeutics Inc involved in embryonic stem cell research?

LockedSign up for free to unlock

Does Keros Therapeutics Inc disclose GHG and Air Emissions intensity?

LockedSign up for free to unlock

Does Keros Therapeutics Inc disclose its waste policy?

LockedSign up for free to unlock

Does Keros Therapeutics Inc report according to TCFD requirements?

LockedSign up for free to unlock

Does Keros Therapeutics Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?

LockedSign up for free to unlock

Does Keros Therapeutics Inc disclose energy use targets?

LockedSign up for free to unlock

Does Keros Therapeutics Inc disclose its Renewable Energy targets?

Only SubscribersSubscription required

Are emissions metrics verified by STBi?

Only SubscribersSubscription required

Does Keros Therapeutics Inc have a policy relating to cyber security?

LockedSign up for free to unlock

Have a different question?

Potential Risks for Keros Therapeutics Inc
These potential risks are based on the size, segment and geographies of the company.

Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed for the treatment of low blood cell counts, or cytopenias, including anemia and thrombocytopenia in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis. It is also developing small molecule product candidate KER-047 that is being developed for the treatment of anemia, as well as for the treatment of fibrodysplasia ossificans progressiva, or FOP, and is currently in a Phase 1 clinical trial; and KER-012 being developed for the treatment of disorders associated with bone loss, such as osteoporosis and osteogenesis imperfecta, and for the treatment of pulmonary arterial hypertension, or PAH. The company was founded in 2015 and is headquartered in Lexington, Massachusetts.

Sorry!

Failed to process!